Evidence method
Level · gp.fundamentals.debt_to_revenue
28.97% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ARQT · Dec 31, 2025
Arcutis Biotherapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001787306-26-000018General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.18% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1.50% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
91.34% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
6.02% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
90.24% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-3.25% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
20.49% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
10.73% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20250/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 109.35%
- Current
- 28.97%
- Delta
- -80.38%
- Previous
- 0.00%
- Current
- 0.18%
- Delta
- 0.18%
- Previous
- -1.77%
- Current
- -1.50%
- Delta
- 0.27%
- Previous
- 121.69%
- Current
- 91.34%
- Delta
- -30.35%
- Previous
- 22.60%
- Current
- 6.02%
- Delta
- -16.58%
- Previous
- 91.25%
- Current
- 90.24%
- Delta
- -1.00%
- Previous
- 8.59%
- Current
- -3.25%
- Delta
- -11.84%
- Previous
- 19.76%
- Current
- 20.49%
- Delta
- 0.73%
- Previous
- 10.11%
- Current
- 10.73%
- Delta
- 0.62%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ARQT Fundamental State →Has State · Arcutis Biotherapeutics, Inc. →Transitioned To · ARQT Fundamental State →Transitioned To · ARQT BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ARQT CAPEX_INTENSITY_INCREASED →Transitioned To · ARQT CASH_GENERATION_INCREASED →Transitioned To · ARQT GROWTH_DECREASED →Transitioned To · ARQT INVENTORY_PRESSURE_DECREASED →Transitioned To · ARQT MARGIN_DECREASED →Transitioned To · ARQT PROFITABILITY_DECREASED →Transitioned To · ARQT R_AND_D_INTENSITY_INCREASED →Transitioned To · ARQT SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.